ARS Pharmaceuticals, Inc. (SPRY)
4.29
+0.06
(+1.42%)
USD |
NASDAQ |
Oct 20, 16:00
4.305
+0.02
(+0.35%)
After-Hours: 20:00
ARS Pharmaceuticals Gross Profit (TTM) : 83.45M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 83.45M |
| March 31, 2026 | 73.37M |
| December 31, 2025 | 63.58M |
| September 30, 2025 | 127.20M |
| June 30, 2025 | 104.82M |
| March 31, 2025 | 94.57M |
| December 31, 2024 | 87.96M |
| September 30, 2024 | 2.394M |
| June 30, 2024 | 0.438M |
| March 31, 2024 | -0.054M |
| December 31, 2023 | -0.043M |
| September 30, 2023 | -0.031M |
| June 30, 2023 | 0.172M |
| March 31, 2023 | -0.306M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.307M |
| September 30, 2022 | -0.123M |
| June 30, 2022 | -0.846M |
| March 31, 2022 | -0.85M |
| December 31, 2021 | -1.929M |
| September 30, 2021 | -1.964M |
| June 30, 2021 | -1.864M |
| March 31, 2021 | -1.775M |
| December 31, 2020 | -1.71M |
| September 30, 2020 | -1.64M |
| June 30, 2020 | -1.199M |
| March 31, 2020 | -0.796M |
| December 31, 2019 | -0.395M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Capricor Therapeutics, Inc. | -2.095M |
| Sionna Therapeutics, Inc. | -0.561M |
| Nektar Therapeutics | 53.90M |
| Ardelyx, Inc. | 422.15M |
| Kyntra Bio, Inc. | 0.076M |